| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,510 | 5,572 | 13:03 | |
| 5,510 | 5,582 | 02.01. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 6,200 | 10.000 | |||
| 6,180 | 10.000 | |||
| 6,100 | 12.150 | |||
| 6,000 | 1.000 | |||
| 5,980 | 860 | |||
| 5,810 | 600 | |||
| 5,800 | 400 | |||
| 5,600 | 5.000 | |||
| 5,528 | 1.485 | |||
| 5,526 | 1.485 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/evt.htm [/URL] | ||||
| 1.485 | 5,504 | |||
| 1.485 | 5,502 | |||
| 500 | 5,410 | |||
| 4.400 | 5,370 | |||
| 140 | 5,300 | |||
| 2.000 | 5,250 | |||
| 1.600 | 5,070 | |||
| 3.000 | 5,050 | |||
| 10.000 | 5,020 | |||
| 1.100 | 5,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 25.710 | 1,672 | 42.980 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 02.01.2026 | 17:35:09 | 5,522 | 190.671 |
| 02.01.2026 | 17:29:44 | 5,533 | 83 |
| 02.01.2026 | 17:29:00 | 5,530 | 102 |
| 02.01.2026 | 17:27:04 | 5,534 | 373 |
| 02.01.2026 | 17:26:15 | 5,536 | 226 |
| 02.01.2026 | 17:26:15 | 5,536 | 156 |
| 02.01.2026 | 17:26:15 | 5,536 | 19 |
| 02.01.2026 | 17:26:15 | 5,536 | 137 |
| 02.01.2026 | 17:25:54 | 5,536 | 43 |
| 02.01.2026 | 17:25:54 | 5,536 | 57 |
| 02.01.2026 | 17:25:11 | 5,534 | 65 |
| 02.01.2026 | 17:24:13 | 5,526 | 215 |
| 02.01.2026 | 17:24:13 | 5,526 | 1 |
| 02.01.2026 | 17:24:13 | 5,526 | 81 |
| 02.01.2026 | 17:23:04 | 5,530 | 313 |
| 02.01.2026 | 17:21:57 | 5,530 | 103 |
| 02.01.2026 | 17:21:15 | 5,520 | 694 |
| 02.01.2026 | 17:21:10 | 5,526 | 254 |
| 02.01.2026 | 17:21:04 | 5,528 | 773 |
| 02.01.2026 | 17:21:04 | 5,520 | 361 |
| Tagesumsatz Xetra | +0,072 +1,32 % | 1,1 Mio. |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 10:26 | EVOTEC SE: Jetzt kippt die Stimmung - ich handle sofort! | 49 | Maximilian Berger | ||
| Fr | Evotec Names Dr. Sarah Fakih as EVP, Head of Global Communications & Investor Relations | 107 | Contract Pharma | ||
| Fr | Evotec SE - 6-K, Report of foreign issuer | 104 | SEC Filings | ||
| Fr | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 586 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| EVOTEC Aktie jetzt für 0€ handeln | |||||
| Fr | EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | 442 | EQS Group (EN) | EQS Voting Rights Announcement: Evotec SE
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Fr | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.01.2026 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 02.01.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.01.2026ISIN NameCA60283L1058 MINERA... ► Artikel lesen | |
| Fr | Gubra A/S: Gubra Announces Expansion of Facilities to Support Continued Growth Across Its Businesses | GlobeNewswire (Europe) | Gubra A/S ("Gubra") today announced a significant expansion of its laboratory and office facilities at DTU Science Park, located in immediate proximity to the company's headquarters in Hørsholm, Denmark.... ► Artikel lesen | |
| 08:00 | Trump reguliert Cannabis-Markt neu - Hidden Champions Bioxyne, GrowGeneration und Emerald erblühen? | Small- & Micro Cap Investment | ||
| Fr | Im Windschatten von Novo Nordisk: Gubra expandiert - neues Hoch | Der Aktionär | Novo Nordisk, Zealand Pharma und Gubra - Dänemark hat gleich drei börsennotierte Unternehmen zu bieten, die vom wachstumsstarken Markt für Adipositas-Medikamente profitieren wollen. Der Wirkstoffforscher... ► Artikel lesen | |
| 06:29 | NurExone schafft Grundlage für First-in-Human-Perspektive mit ExoPTEN | Small- & Micro Cap Investment |